Beximco Pharmaceuticals (DHA:BXPHARMA) Net Interest Margin (Bank Only) %

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

DHA:BXPHARMA Beximco Pharmaceuticals PLC DHA:BXPHARMA
94 GF Score
Price BDT150.90
GF Value BDT128.18
Valuation Modestly Overvalued
! 5 Warning Signs
View Full Analysis

What is Beximco Pharmaceuticals Net Interest Margin (Bank Only) %?

Net Interest Margin (Bank Only) % only applies to banks.

DHA:BXPHARMA
94GF Score
Beximco Pharmaceuticals PLC DHA:BXPHARMA
Net Interest Margin (Bank Only) % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Beximco Pharmaceuticals (DHA:BXPHARMA) Overvalued in 2026?

Based on GuruFocus' analysis, Beximco Pharmaceuticals stock appears to be overvalued. The current stock price of BDT150.90 is trading 17.7% above its estimated GF Value™ of BDT128.18. GuruFocus considers Beximco Pharmaceuticals to be Modestly Overvalued.

Key valuation signals for DHA:BXPHARMA:

  • Net Interest Margin (Bank Only) %:
  • GF Value™: BDT128.18 vs. price of BDT150.90 (17.7% above fair value)
  • GF Score™: 94/100 with 5 warning signs

No single metric tells the full story. See the DHA:BXPHARMA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Beximco Pharmaceuticals Business Description

Other Exchanges BXP:UKR2WA:Germany
Address 19 Dhanmondi, Road No. 7, Dhaka, BGD, 1205
Beximco Pharmaceuticals PLC is engaged in manufacturing and marketing a wide range of generic pharmaceutical formulation products, life-saving intravenous fluids, therapeutic nutrition products, and Active Pharmaceutical Ingredients. It manufactures various pharmaceutical products including oral contraceptives, hormones, steroids, anti-histamine, anti-fibrinolytic, cardiac, musculoskeletal, respiratory, vitamin & mineral supplements, women's health products, and others. The products of the company are sold in domestic and international markets. Key revenue accrues from domestic sales.
94GF Score

Get the complete analysis for DHA:BXPHARMA

Net Interest Margin (Bank Only) % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

BDT150.90
Price
BDT128.18
GF Value